Non-ischemic Cardiomyopathy
36
12
13
8
Key Insights
Highlights
Success Rate
62% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.9%
5 terminated out of 36 trials
61.5%
-25.0% vs benchmark
6%
2 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (36)
Metabolomic Profiling in Ischemic and Non-Ischemic Cardiomyopathy Patients With Ventricular Arrhythmias
Longitudinal Validation of CIRC Technologies
Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead
Cardiac Magnetic Resonance for Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy
Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada
Left Ventricular Structural Predictors of Sudden Cardiac Death
Cardiac RadiothErapy For hEart faiLure
Non-ischemic Cardiomyopathy Registry, Biobank and Imaging Data Repository
Assessment of Combined CCM and ICD Device in HFrEF
Gut Microbiome Profiling in Patients With Chronic Heart Failure
The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure
Development of CIRC Technologies
Electrogram-Guided Myocardial Advanced Phenotyping
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
Cardiovascular Multimodality Imaging Study
Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.
Implantable Cardioverter Defibrillator (ICD Registry)
Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies